Epidemiology References

CRUK (Cancer Research UK) 2014: Chronic lymphocytic leukaemia (CLL) incidence statistics. Updated June 2014 [Accessed March 2017]; and UK Cancer incidence (2011) and mortality (2012) summary – rates. September 2014 [Both accessed October 2017]. Available from: http://www.cancerresearchuk.org

Gibson J, Iland HJ Larsen, Brown CM, Joshua DE. Leukaemias into the 21st century – part 2: the chronic leukaemias. Intern Med J. 2013;43:484–94.

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al., Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524-48.

Hallek M. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification and treatment. Am J Hematol. 2017;92:946–65.

Holtzer-Goor KM, Schaafsma MR, Joosten P, Posthuma EF, Wittebol S, Huijgens PC, et al. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study. Qual Life Res. 2015;24:2895-906.

Jain P, Rai KR. Overview of recent developments in chronic lymphocytic leukemia. South Asian J Cancer. 2012;1(2):84–9.

Oscier D, Dearden C, Erem E, Fegan C, Follows G, Hillmen P, et al. Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. Br J Haematol. 2012;159:541–64.

Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C. Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia. Support Care Cancer. 2013;21:2853–60.

Pulte D, Redaniel MT, Bird J, Jeffreys M. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century. Eur J Haematol. 2015;94:540-5.

Ruchlemer R, Zatlawi M, Fishler Y, Dichtair R, Silverman B, Aviv A, et al. Cancer registries often underestimate the true incidence of CLL. XVI International Workshop on Chronic Lymphocytic Leukemia 2015; Abstract 62.

Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105:1684–92.